search
Back to results

mHealth Technologies to Enhance PrEP Adherence Among Thai MSM (P3-T)

Primary Purpose

Adherence, Patient, Pre-Exposure Prophylaxis, HIV/AIDS

Status
Completed
Phase
Not Applicable
Locations
Thailand
Study Type
Interventional
Intervention
P3-T PrEP Adherence App
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Adherence, Patient focused on measuring PrEP adherence, HIV, Young men who have sex with men, YMSM, Thailand, Mobile app, mHealth

Eligibility Criteria

16 Years - 24 Years (Child, Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria

  • Male sex at birth
  • Gender identity is male
  • Identify as a man who has sex with men
  • Ages 16-24
  • Plan to start PrEP in next 14 days
  • Able to speak and read Thai
  • Own an Android or iOS smartphone

Exclusion Criteria:

  • Currently participating in another experimental PrEP adherence intervention
  • Plan to move out of Bangkok in the next 6 months
  • Unable to be consented due to an active substance use or psychological condition

Sites / Locations

  • Chulalongkorn University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

P3-T PrEP adherence app

Standard of Care

Arm Description

Intended app use includes, at a minimum, participant completion of selected app activities (medication tracking, daily quest, social wall post) each day for the 3 month intervention period. Participant completion of Standard of Care PrEP adherence and sexual risk behavior counseling at the 1-month post-prescription visit and the 4-month post-prescription visit.

Participant completion of Standard of Care PrEP adherence and sexual risk behavior counseling at the 1-month post-prescription visit and the 4-month post-prescription visit.

Outcomes

Primary Outcome Measures

Intervention Feasibility: Average proportion of days of any app use
The average proportion of days of any app use during the trial across all participants as recorded by backend app metrics. Total possible range: 0-1. Higher proportion indicates higher intervention feasibility.
Intervention Feasibility: Average proportion of days of PrEP medication tracked
The average proportion of days participants used the app to track PrEP medication taking. Total possible range: 0 - 1. Higher proportion indicates higher intervention feasibility.
Intervention Acceptability: Mean intervention acceptability, composite score CSQ-8
The mean composite score calculated from the Client Satisfaction Questionnaire (CSQ-8), an 8-item validated scale measuring the construct of global intervention satisfaction. Total possible composite score range: 8 (lowest acceptability, worst outcome) to 32 (highest acceptable, best outcome).

Secondary Outcome Measures

Difference in PrEP medication adherence between study arms at Month 3
Comparison of the proportion of participants with protective levels of tenofovir-diphosphate (TFV-DP)/emtricitabine triphosphate (FTC-TP) at month 3 between the study arms.
Difference in PrEP medication adherence between study arms at Month 6
Comparison of the proportion of participants with protective levels of TFV-DP/FTC-TP at month 6 between the study arms.

Full Information

First Posted
May 29, 2020
Last Updated
September 27, 2021
Sponsor
Duke University
Collaborators
University of North Carolina, Chapel Hill, Chulalongkorn University, Thai Red Cross AIDS Research Centre
search

1. Study Identification

Unique Protocol Identification Number
NCT04413708
Brief Title
mHealth Technologies to Enhance PrEP Adherence Among Thai MSM
Acronym
P3-T
Official Title
Novel mHealth Technologies to Enhance PrEP Adherence Among Thai MSM: Collaborative Adaptation and Evaluation
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Completed
Study Start Date
June 12, 2020 (Actual)
Primary Completion Date
August 10, 2021 (Actual)
Study Completion Date
August 10, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University
Collaborators
University of North Carolina, Chapel Hill, Chulalongkorn University, Thai Red Cross AIDS Research Centre

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to: 1) adapt the theory-based P3 (Prepared, Protected, emPowered) app designed to improve pre-exposure prophylaxis (PrEP) adherence, retention in PrEP clinical care, and PrEP persistence among young men who have sex with men (YMSM) in the United States for YMSM in Thailand, and 2) conduct a pilot randomized controlled trial (RCT) to assess the feasibility, acceptability, and potential impact of the adapted P3-Thailand (P3-T) app.
Detailed Description
This R21 study, titled "Novel mHealth Technologies to Enhance PrEP Adherence among Thai MSM: Collaborative Adaptation and Evaluation", is: 1) adapting the theory-based smartphone app, P3, designed to improve PrEP adherence, retention in PrEP clinical care, and PrEP persistence among YMSM in the United States for YMSM in Thailand, and 2) conducting a pilot RCT to assess the feasibility and acceptability of the adapted P3-T app and to examine the potential impact of the app on PrEP adherence. The study is a partnership between Duke University, Chulalongkorn University, Thai Red Cross AIDS Research Centre (TRC-ARC), and the University of North Carolina-Chapel Hill, and includes a robust plan to increase mHealth capacity at Chulalongkorn University and TRC-ARC. P3 is a theory-based, comprehensive smartphone app platform for YMSM that utilizes social networking and game-based mechanics as well as evidenced-based features to improve PrEP medication adherence. P3 is a product born from the collaborative effort of researchers and health game developers working closely with members of the target population in the United States. Built on a successful, evidence-based platform designed by our collaborating technology partner, Ayogo, and tested by our study team, P3 is flexible, allowing for customization and adaptations for different cultural and linguistic contexts, and responsive to changes in technology. The social networking features of P3 are designed to capitalize on social involvement as a means through which YMSM can receive information and social support, experience social norms and reflective appraisals, and feel a sense of connectedness to peers. Peers have been recognized as a highly important source of sexual health and HIV prevention information and support among Thai YMSM. The gaming features of P3 are goal-oriented and immersive and provide a challenging and motivating environment for behavior change. As a result, P3 is ideal for engaging YMSM in behavior change, by maintaining attention, avoiding boredom and attrition. The pilot RCT of the adapted P3-T app with be conducted with 60 YMSM newly starting PrEP in Thailand to: 1) assess app feasibility and acceptability, and 2) explore the potential impact of the app on PrEP adherence. The study will be 6 months in duration with a 3-month intervention period and include study visits at baseline, 3-months, and 6-months. At baseline, participants will complete a baseline web-based computer-assisted self-interviewing (CASI) survey. Next, participants will be randomized in a 1:1 ratio into the P3-T arm or standard of care (SOC) study arm. All study participants will complete follow-up CASI surveys and have their blood drawn via venipuncture at 3 and 6 months for collection of dried blood spots (DBS). In-depth interviews will be conducted with 10 P3-T arm participants after the 3-month intervention period. The interview will ask participants about their experience and impressions of the app, how they used it, and how it may have impacted their behaviors during the 3-month intervention period.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Adherence, Patient, Pre-Exposure Prophylaxis, HIV/AIDS
Keywords
PrEP adherence, HIV, Young men who have sex with men, YMSM, Thailand, Mobile app, mHealth

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
P3-T PrEP adherence app
Arm Type
Experimental
Arm Description
Intended app use includes, at a minimum, participant completion of selected app activities (medication tracking, daily quest, social wall post) each day for the 3 month intervention period. Participant completion of Standard of Care PrEP adherence and sexual risk behavior counseling at the 1-month post-prescription visit and the 4-month post-prescription visit.
Arm Title
Standard of Care
Arm Type
No Intervention
Arm Description
Participant completion of Standard of Care PrEP adherence and sexual risk behavior counseling at the 1-month post-prescription visit and the 4-month post-prescription visit.
Intervention Type
Behavioral
Intervention Name(s)
P3-T PrEP Adherence App
Other Intervention Name(s)
P3-T
Intervention Description
P3-T provides daily PrEP reminders, a medication tracker and calendar, personalized medication adherence strategies, refill reminders, and tailored adherence support messages; social support via a social wall that includes daily discussion prompts; daily quests to build knowledge and skills; a multimedia knowledge center; interactive narrative collections; personalized adherence counseling provided by an adherence counselor via in-app messaging; in-app rewards; a "bank account" that rewards daily app use by adding or subtracting a small financial reward based on daily app use; and, a user profile that includes a user-selected avatar.
Primary Outcome Measure Information:
Title
Intervention Feasibility: Average proportion of days of any app use
Description
The average proportion of days of any app use during the trial across all participants as recorded by backend app metrics. Total possible range: 0-1. Higher proportion indicates higher intervention feasibility.
Time Frame
3 Months
Title
Intervention Feasibility: Average proportion of days of PrEP medication tracked
Description
The average proportion of days participants used the app to track PrEP medication taking. Total possible range: 0 - 1. Higher proportion indicates higher intervention feasibility.
Time Frame
Month 3
Title
Intervention Acceptability: Mean intervention acceptability, composite score CSQ-8
Description
The mean composite score calculated from the Client Satisfaction Questionnaire (CSQ-8), an 8-item validated scale measuring the construct of global intervention satisfaction. Total possible composite score range: 8 (lowest acceptability, worst outcome) to 32 (highest acceptable, best outcome).
Time Frame
Month 3
Secondary Outcome Measure Information:
Title
Difference in PrEP medication adherence between study arms at Month 3
Description
Comparison of the proportion of participants with protective levels of tenofovir-diphosphate (TFV-DP)/emtricitabine triphosphate (FTC-TP) at month 3 between the study arms.
Time Frame
Month 3
Title
Difference in PrEP medication adherence between study arms at Month 6
Description
Comparison of the proportion of participants with protective levels of TFV-DP/FTC-TP at month 6 between the study arms.
Time Frame
Month 6

10. Eligibility

Sex
Male
Gender Based
Yes
Gender Eligibility Description
Self-identify as male
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
24 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria Male sex at birth Gender identity is male Identify as a man who has sex with men Ages 16-24 Plan to start PrEP in next 14 days Able to speak and read Thai Own an Android or iOS smartphone Exclusion Criteria: Currently participating in another experimental PrEP adherence intervention Plan to move out of Bangkok in the next 6 months Unable to be consented due to an active substance use or psychological condition
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sara LeGrand, Ph.D.
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chulalongkorn University
City
Bangkok
ZIP/Postal Code
10330
Country
Thailand

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34734828
Citation
Songtaweesin WN, LeGrand S, Bandara S, Piccone C, Wongharn P, Moonwong J, Jupimai T, Saisaengjan C, Theerawit T, Muessig K, Hightow-Weidman L, Puthanakit T, Phanuphak N, Tangmunkongvorakul A. Adaptation of a Theory-Based Social Networking and Gamified App-Based Intervention to Improve Pre-Exposure Prophylaxis Adherence Among Young Men Who Have Sex With Men in Bangkok, Thailand: Qualitative Study. J Med Internet Res. 2021 Nov 4;23(11):e23852. doi: 10.2196/23852.
Results Reference
derived

Learn more about this trial

mHealth Technologies to Enhance PrEP Adherence Among Thai MSM

We'll reach out to this number within 24 hrs